Prognostic role of common MicroRNA polymorphisms in cancers: Evidence from a meta-analysis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Xia, Lingzi ^a,b   Ren, Yangwu ^a,b   Fang, Xue ^a,b   Yin, Zhihua ^a,b   Li, Xuelian ^a,b   Wu, Wei ^a,b   Guan, Peng ^a,b   Zhou, Baosen ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Rural Economic Institute of Liaoning Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 149; MICRORNA 196A2; MICRORNA 499; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CAUCASIAN; DIGESTIVE SYSTEM CANCER; DISEASE FREE SURVIVAL; ETHNIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; PATHOLOGY; PROGNOSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR RECURRENCE;

ALLELES; DISEASE-FREE SURVIVAL; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 84908540411     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106799     Document Type: Article

References (50)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al. (2012) GLOBOCAN 2012 V1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 in.
2. Lyon F (2013) International Agency for Research on Cancer in.
3. Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the Human Development Index(2008-2030): a population-based study. Lancet Oncology 13: 790-801.
4. Huang D, Wang H, Liu R, Li H, Ge S, et al. (2014) miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer. Journal of Cellular Biochemistry 115: 549-556.
5. Xia X, Yang B, Zhai X, Liu X, Shen K, et al. (2013) Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. PloS one 8: e80426.
6. CHEN J-p, HU Z-b, TIAN T, ZHOU X-y, MIAO R-f, et al. (2009) Single nucleotide polymorphism associated with mature miR-196a2 influences the expression of Lymphocyte-specific protein 1 (LSP1) gene. ACTA UNIVERSITATIS MEDICINALIS NANJING (Natural Science) 29: 762-766.
7. Wang S, Tao G, Wu D, Zhu H, Gao Y, et al. (2013) A functional polymorphism in MIR196A2 is associated with risk and prognosis of gastric cancer. Molecular carcinogenesis 52 Suppl 1: E87-95.
8. Olivieri F, Lazzarini R, Babini L, Prattichizzo F, Rippo MR, et al (2013) Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation. Free radical biology & medicine 63: 410-20.
9. Zhu K, Pan Q, Zhang X, Kong LQ, Fan J, et al. (2013) MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. Carcinogenesis 34: 2071-9.
10. Chaudhry MA, Omaruddin RA, Brumbaugh CD, Tariq MA, Pourmand N (2013) Identification of radiation-induced microRNA transcriptome by next-generation massively parallel sequencing. Journal of radiation research 54: 808-22.
11. Yao Q, Cao Z, Tu C, Zhao Y, Liu H, et al. (2013) MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer letters 335: 219-24.
12. Li Y, Zhang M, Chen H, Dong Z, Ganapathy V, et al. (2010) Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer research 70: 7894-904.
13. Ke Y, Zhao W, Xiong J, Cao R (2013) miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1. Biochemistry research international 2013: 506731.
14. Ding SL, Wang JX, Jiao JQ, Tu X, Wang Q, et al. (2013) A pre-microRNA-149 (miR-149) genetic variation affects miR-149 maturation and its ability to regulate the Puma protein in apoptosis. The Journal of biological chemistry 288: 26865-77.
15. Wang Y, Zheng X, Zhang Z, Zhou J, Zhao G, et al. (2012) MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. PloS one 7: e41693.
16. ∗ induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Molecular carcinogenesis 49: 719-27.
17. Pan S, Zhang S, Pei B, Sun Q, Bian L, et al. (2012) MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY 25: 871-881.
18. Omrani M, Hashemi M, Eskandari-Nasab E, Hasani S, Mashhadi M, et al. (2014) hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomarkers Med 8: 259-267.
19. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-9.
20. Xiong X-d, Cho M, Cai X-p, Cheng J, Jing X, et al. (2014) A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 761: 15-20.
21. Ramkaran P, Khan S, Phulukdaree A, Moodley D, Chuturgoon AA (2014) miR-146a Polymorphism Influences Levels of miR-146a, IRAK-1, and TRAF-6 in Young Patients with Coronary Artery Disease. Cell Biochemistry and Biophysics 68: 259-266.
22. Ding S-L, Wang J-X, Jiao J-Q, Tu X, Wang Q, et al. (2013) A Pre-microRNA-149 (miR-149) Genetic Variation Affects miR-149 Maturation and Its Ability to Regulate the Puma Protein in Apoptosis. Journal of Biological Chemistry 288: 26865-26877.
23. Permuth-Wey J, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, et al. (2011) A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. Journal of neuro-oncology 105: 639-46.
24. Ahn DH, Rah H, Choi YK, Jeon YJ, Min KT, et al. (2013) Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Molecular carcinogenesis 52 Suppl 1: E39-51.
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology - A proposal for reporting. JAMA-J Am Med Assoc 283: 2008-2012.
26. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in cardiovascular diseases 27: 335-71.
27. Sterne JAC, Egger M (2001) Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. Journal of Clinical Epidemiology 54: 1046-1055.
28. Chae YS, Kim JG, Lee SJ, Kang BW, Lee YJ, et al. (2013) A miR-146a Polymorphism (rs2910164) Predicts Risk of and Survival from Colorectal Cancer. anticancer research 33: 3233-3240.
29. Hong MJ, Choi YY, Jang JA, Jung HJ, Lee SY, et al. (2013) Association between Genetic Variants in Pre-MicroRNAs and Survival of Early-Stage NSCLC. J THORAC ONCOL 8: 703-710.
30. Umar M, Upadhyay R, Prakash G, Kumar S, Ghoshal UC, et al. (2013) Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer. Molecular carcinogenesis 52 Suppl 1: E10-8.
31. Kim WH, Min KT, Jeon YJ, Kwon CI, Ko KH, et al. (2012) Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 504: 92-7.
32. Wang M, Chu H, Li P, Yuan L, Fu G, et al. (2012) Genetic variants in miRNAs predict bladder cancer risk and recurrence. Cancer research 72: 6173-82.
33. Guan X, Sturgis EM, Song X, Liu Z, El-Naggar AK, et al. (2013) Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Cancer letters 330: 233-40.
34. Jang MJ, Kim JW, Min KT, Jeon YJ, Oh D, et al. (2011) Prognostic significance of microRNA gene polymorphisms in patients with surgically resected colorectal cancer. Experimental and therapeutic medicine 2: 1127-1132.
35. Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, et al. (2012) The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. The Journal of thoracic and cardiovascular surgery 144: 794-807.
36. Tu HF, Liu CJ, Chang CL, Wang PW, Kao SY, et al. (2012) The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. PloS one 7: e51606.
37. Hu Z, Chen J, Tian T, Zhou X, Gu H, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. The Journal of clinical investigation 118: 2600-8.
38. Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, et al. (2010) Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 16: 3713-20.
39. Kim HY, Yoon JH, Lee HS, Cheong JY, Cho SW, et al. (2014) MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B. Journal of medical virology 86: 446-53.
40. Liu CJ, Tsai MM, Tu HF, Lui MT, Cheng HW, et al. (2013) miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas. Annals of surgical oncology 20 Suppl 3: S406-14.
41. Navarro A, Munoz C, Gaya A, Diaz-Beya M, Gel B, et al. (2013) MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients. PloS one 8: e64716.
42. Zhang B (2013) Single Nucleotide Polymorphisms of CASP-8 Genes, MicroRNA genes and Susceptibility and Prognosis of Malignant Lymphoma, Third Military Medical University.
43. Wu C, Li M, Hu C, Duan H (2014) Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy. Cancer chemotherapy and pharmacology 73: 335-41.
44. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, et al. (2010) Association between common genetic variants in pre-microRNAs and the clinicopathological characteristics and survival of gastric cancer patients. Experimental and therapeutic medicine 1: 1035-1040.
45. Dikeakos P, Theodoropoulos G, Rizos S, Tzanakis N, Zografos G, et al. (2014) Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Molecular biology reports 41: 1075-80.
46. Chae YS, Kim JG, Kang BW, Lee SJ, Lee YJ, et al. (2013) Functional Polymorphism in the MicroRNA-367 Binding Site as a Prognostic Factor for Colonic Cancer. Anticancer Research: 513-520.
47. Zheng J, Deng J, Xiao M, Yang L, Zhang L, et al. (2013) A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopha-ryngeal carcinoma. Cancer research 73: 5151-62.
48. Xing J, Wan S, Zhou F, Qu F, Li B, et al. (2012) Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. cancer epidemiol biomarkers prev 21: 217-227.
49. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, et al. (2010) Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 31: 1805-12.
50. Stenholm L, Stoehlmacher-Williams J, Al-Batran SE, Heussen N, Akin S, et al. (2013) Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 24: 2581-8.